1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Trauma Resuscitation with Group O Whole Blood Or Products (TROOP) Trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This is a pragmatic, multicenter, phase III randomized clinical trial comparing the effectiveness and safety of whole blood with component blood therapy in trauma patients requiring large volume transfusions.
The trial aims to transform how massively bleeding trauma patients are transfused and reduce preventable deaths from hemorrhagic shock.
Get alerted about grants like this
Save a search for “National Heart, Lung, and Blood Institute (NHLBI)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Primarily for institutions conducting clinical trials, such as major trauma centers and university hospitals. The Clinical Coordinating Center is at the University of Alabama at Birmingham, and the Data Coordinating Center is at the University of Texas Health Science Center at Houston. Confirm the full requirements in the official notice before applying.
Trauma Resuscitation with Group O Whole Blood Or Products (TROOP) Trial is funded by National Heart, Lung, and Blood Institute (NHLBI). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Alabama and Texas. Check the official notice for exact location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Single Source: Cardiothoracic Surgical Trials Network (CTSN) Data Coordinating Center (U01 Clinical Trial Required) is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This opportunity seeks a single institution to serve as the Data Coordinating Center for the Cardiothoracic Surgical Trials Network (CTSN), responsible for data management, statistical analysis, and operational support for multi-center clinical trials.
HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials - Clinical Trial Center and Clinical Centers (U01 Clinical Trial Optional) is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. Supports clinical trial centers and clinical centers for refining heart failure subtypes and treatment targets for personalized clinical trials.
Growing Data-science Research in Africa to Stimulate Progress (GRASP) is sponsored by National Heart, Lung, and Blood Institute (NHLBI) / NIH. The GRASP program supports data-science research in Africa to stimulate progress. While the provided information is an award notice, it indicates an active program with a performance end date in July 2026, suggesting ongoing or upcoming related opportunities. The NIH supports a diverse mix of research projects in Sub-Saharan Africa.
The $46M FSHARP program is creating shelf-stable synthetic blood from freeze-dried components. A new SWiFT SBIR topic opened May 6 for autonomous field transfusion devices. What grant seekers in biomedical engineering need to know.
Read articleDARPA MTO opened six FY26 SBIR topics on May 27 with a June 24 deadline — nanopore proteomics, compact RF filters, 800°C ICs, passive thermal spreaders, radiation-hardened codesign, and low-resource computing. The topics read like a wishlist for the next decade of contested-environment microelectronics. Here is what each one is actually asking for, and how small businesses should triage the four-week window.
Read article